Zimmer Biomet Holdings, Inc. Revenue 2007–2025
Zimmer Biomet Holdings, Inc. reported $8.23B of revenue for fiscal 2025. That was 7.2% higher than fiscal 2024. Compared with fiscal 2020, the change was +34.3%.
| Fiscal year | Revenue | Change (YoY) |
|---|---|---|
| FY 2025 | $8.23B | +7.2% |
| FY 2024 | $7.68B | +3.8% |
| FY 2023 | $7.39B | +6.5% |
| FY 2022 | $6.94B | +1.6% |
| FY 2021 | $6.83B | +11.4% |
| FY 2020 | $6.13B | -23.2% |
| FY 2019 | $7.98B | +0.6% |
| FY 2018 | $7.93B | +1.7% |
| FY 2017 | $7.80B | +1.8% |
| FY 2016 | $7.67B | — |
| FY 2015 | $0 | — |
| FY 2014 | $0 | — |
| FY 2013 | $0 | — |
| FY 2012 | $0 | — |
| FY 2011 | $0 | -100.0% |
| FY 2010 | $4.22B | +3.0% |
| FY 2009 | $4.10B | -0.6% |
| FY 2008 | $4.12B | +5.7% |
| FY 2007 | $3.90B | — |
Source: Zimmer Biomet Holdings, Inc. SEC filings — income statement (10-K). Computed deterministically; refreshed nightly (last updated August 2, 2026). Open ZBH 10-K filings at SEC EDGAR · Methodology · Download CSV.
How to read this history
Zimmer Biomet Holdings, Inc. reported $8.23B of revenue for fiscal 2025. That was 7.2% higher than fiscal 2024. Compared with fiscal 2020, the change was +34.3%. Values remain missing when the cached filing does not disclose a comparable line item; they are never estimated. Stock splits, reorganizations and fiscal-calendar changes can reduce comparability.
Prepared and reviewed by the stockportfolio.pro research desk. Corrections: support@stockportfolio.pro.
See the full picture for Zimmer Biomet Holdings, Inc.
Complete income statement, balance sheet and cash flow with trend on every row, 48 quarters, ratios, health checks, and Ask — the SEC-grounded research assistant.
Open the interactive view — freeZimmer Biomet Holdings, Inc. — frequently asked questions
What is Zimmer Biomet Holdings, Inc.'s revenue?
Zimmer Biomet Holdings, Inc. (ZBH) reported revenue of $8.23B for fiscal year 2025, per its SEC filings.
How has Zimmer Biomet Holdings, Inc.'s revenue changed over time?
Between fiscal 2007 and 2025, ZBH's revenue grew at roughly 4.2% per year (compound annual rate), from $3.90B to $8.23B.
Where does this data come from?
Figures are computed from Zimmer Biomet Holdings, Inc.'s official SEC filings (income statement (10-K)), refreshed nightly. Not investment advice.